Meridian Biosciences, Inc.

Financial Analysts: Ananth Venkatachalam, Tori Diersen

Junior Financial Analysts: Adam Beer, Guilber Sorto, Nate Meister, Matthew Mugabo

Presented on: March 31, 2021

Price at Pitch: $26.26

Industry: Healthcare

Competition Placing: Second

Club Voting Decision, %: Buy, 70.9%